pyruvaldehyde has been researched along with Liver Cirrhosis in 3 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Michel, M | 2 |
Hess, C | 1 |
Kaps, L | 1 |
Kremer, WM | 1 |
Hilscher, M | 1 |
Galle, PR | 1 |
Moehler, M | 1 |
Schattenberg, JM | 1 |
Wörns, MA | 1 |
Labenz, C | 1 |
Nagel, M | 1 |
Hollenbach, M | 1 |
Thonig, A | 1 |
Pohl, S | 1 |
Ripoll, C | 1 |
Zipprich, A | 1 |
Ahmed, N | 1 |
Thornalley, PJ | 1 |
Lüthen, R | 1 |
Häussinger, D | 1 |
Sebekova, K | 1 |
Schinzel, R | 1 |
Voelker, W | 1 |
Heidland, A | 1 |
3 other studies available for pyruvaldehyde and Liver Cirrhosis
Article | Year |
---|---|
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis.
Topics: Aged; Cohort Studies; Female; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Pyru | 2021 |
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
Topics: Animals; Cells, Cultured; Cytokines; Glutathione; Inflammation; Lactoylglutathione Lyase; Liver; Liv | 2017 |
Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
Topics: Adult; Aged; Biomarkers; Blood Proteins; Case-Control Studies; Female; Glycation End Products, Advan | 2004 |